Michael Malafronte Purchases 1,200 Shares of Adtalem Global Education (NYSE:CVSA) Stock

Adtalem Global Education Inc. (NYSE:CVSA) Director Michael Malafronte acquired 1,200 shares of the firm’s stock in a transaction on Tuesday, March 3rd. The shares were acquired at an average price of $97.97 per share, with a total value of $117,564.00. Following the completion of the purchase, the director owned 1,200 shares of the company’s stock, valued at $117,564. This trade represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Adtalem Global Education Price Performance

Adtalem Global Education stock opened at $102.07 on Friday. Adtalem Global Education Inc. has a 52-week low of $86.26 and a 52-week high of $156.26. The company has a quick ratio of 0.68, a current ratio of 0.68 and a debt-to-equity ratio of 0.37. The firm has a market capitalization of $3.52 billion, a PE ratio of 13.15, a price-to-earnings-growth ratio of 0.86 and a beta of 0.72.

Adtalem Global Education (NYSE:CVSA) last posted its earnings results on Wednesday, January 28th. The company reported $2.43 earnings per share for the quarter. Adtalem Global Education had a net margin of 13.41% and a return on equity of 20.24%. The business had revenue of $503.39 million for the quarter.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on CVSA shares. Barrington Research reaffirmed an “outperform” rating and issued a $170.00 target price on shares of Adtalem Global Education in a research report on Monday, March 2nd. Zacks Research upgraded Adtalem Global Education from a “hold” rating to a “strong-buy” rating in a report on Tuesday, February 24th. Finally, Weiss Ratings began coverage on Adtalem Global Education in a research report on Wednesday, February 25th. They set a “hold (c+)” rating on the stock. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Buy” and an average target price of $170.00.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.